4Vermeer SE,Prins ND,den Heijer T,et al.Silent brain infacts and the risk of dementia and cognitive decline.N Engl J Med,2003,348:1215-1222.
5Heyman A,Fillenbaum GG,Welsh-Bohmer KA,et al.Cerebral infarcts in patients with autopsy-proven Alzheimer's disease:CERAD,part XⅧ.Consortium to Establish a Registry for Alzheimer's Disease.Neurology,1998,51:159-162.
6Whitehead SN,Hachinski VC,Cechetto DF.Interaction between a rat model of cerebral ischemia and β-amyloid toxicity:inflammatory responses.Stroke,2005,36:107-112.
7Shi J,Yang SH,Stubley L,et al.Hypoperfusion induces overexpression ofβ-amyloid precursor protein mRNA in a focal ischemic rodent model.Brain Res,2000,853:1-4.
8Li R,Lindholm K,Yang LB,et al.Amyloid β peptide load is correlated with increased β-secretase activity in sporadic Alzheimer's disease patients.Proc Natl Acad Sci USA,2004,101:3632-3637.
9Shibata M,Yamada S,Kumar SR,et al.Clearance of Alzheimer's amyloid-ss(1 40) peptide from brain by LDL receptor-related protein-1at the blood-brain barrier.J Clin Invest,2000,106:1489-1499.
10Stadelmann C,Deckwerth TL,Srinivasan A,et al.Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease.Evidence for apoptotic cell death.Am J Pathol,1999,155:1459-1466.